Skip to main content
OpenTrials
Completed

NCT Number: NCT00175461

Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Vancouver General Hospital

Vancouver, British Columbia, V5Z 1L8, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

No contralateral hip symptoms, no major comorbidity

Exclusion criteria

-

Treatment and study plan

Hip surgery

Procedure

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

Primary outcomes

  1. 3-months WOMAC score

    Time frame: 3 months

Secondary outcomes

  1. Cost-effectiveness at 2-years

    Time frame: Two years

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

Comparison of the Clinical Effectiveness and Cost-effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty

Important dates

Study start
2005
Primary completion
2009
Study completion
2011
First posted
Sep 15, 2005
Registry last updated
Mar 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.